The murine Microenvironment Cell Population counter method to estimate abundance of tissue-infiltrating immune and stromal cell populations in murine samples using gene expression.


Journal

Genome medicine
ISSN: 1756-994X
Titre abrégé: Genome Med
Pays: England
ID NLM: 101475844

Informations de publication

Date de publication:
06 10 2020
Historique:
received: 30 03 2020
accepted: 14 09 2020
entrez: 7 10 2020
pubmed: 8 10 2020
medline: 4 8 2021
Statut: epublish

Résumé

Quantifying tissue-infiltrating immune and stromal cells provides clinically relevant information for various diseases. While numerous methods can quantify immune or stromal cells in human tissue samples from transcriptomic data, few are available for mouse studies. We introduce murine Microenvironment Cell Population counter (mMCP-counter), a method based on highly specific transcriptomic markers that accurately quantify 16 immune and stromal murine cell populations. We validated mMCP-counter with flow cytometry data and showed that mMCP-counter outperforms existing methods. We showed that mMCP-counter scores are predictive of response to immune checkpoint blockade in cancer mouse models and identify early immune impacts of Alzheimer's disease.

Identifiants

pubmed: 33023656
doi: 10.1186/s13073-020-00783-w
pii: 10.1186/s13073-020-00783-w
pmc: PMC7541325
doi:

Substances chimiques

Biomarkers 0
Immune Checkpoint Inhibitors 0
Immune Checkpoint Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

86

Références

Toxicol Pathol. 2014 Jan;42(1):99-110
pubmed: 24231829
Nat Rev Genet. 2019 Dec;20(12):724-746
pubmed: 31515541
Nat Rev Cancer. 2006 May;6(5):392-401
pubmed: 16572188
Nucleic Acids Res. 2019 Jan 8;47(D1):D780-D785
pubmed: 30395284
Bioinformatics. 2014 Oct;30(19):2811-2
pubmed: 24930139
Immunity. 2007 Jun;26(6):669-73
pubmed: 17582339
Genome Biol. 2016 Oct 20;17(1):218
pubmed: 27765066
Clin Rev Allergy Immunol. 2012 Feb;42(1):35-44
pubmed: 22105703
Nat Rev Cancer. 2012 Mar 15;12(4):298-306
pubmed: 22419253
Nature. 2015 Feb 19;518(7539):365-9
pubmed: 25693568
Nat Immunol. 2008 Oct;9(10):1091-4
pubmed: 18800157
Nucleic Acids Res. 2020 Jan 8;48(D1):D77-D83
pubmed: 31665515
Biostatistics. 2010 Apr;11(2):242-53
pubmed: 20097884
Nat Biotechnol. 2019 Jul;37(7):773-782
pubmed: 31061481
Bioinformatics. 2019 Jul 15;35(14):i436-i445
pubmed: 31510660
Front Immunol. 2018 Jun 05;9:1286
pubmed: 29922297
Eur Respir J. 2003 Aug;22(2):374-82
pubmed: 12952276
Sci Transl Med. 2019 Jul 17;11(501):
pubmed: 31316010
Lipids Health Dis. 2017 Jan 17;16(1):12
pubmed: 28095860
Biostatistics. 2007 Jan;8(1):118-27
pubmed: 16632515
Mol Syst Biol. 2014 Feb 28;10:720
pubmed: 24586061
Cancer Immunol Immunother. 2018 Jul;67(7):1031-1040
pubmed: 29541787
Semin Oncol. 2002 Dec;29(6 Suppl 16):15-8
pubmed: 12516034
Nat Methods. 2015 May;12(5):453-7
pubmed: 25822800
Neuron. 2003 Oct 30;40(3):471-83
pubmed: 14642273
Immunity. 2014 Aug 21;41(2):191-206
pubmed: 25148023
J Neural Transm (Vienna). 2009 May;116(5):587-97
pubmed: 19370387
Cancer Cell. 2018 Mar 12;33(3):463-479.e10
pubmed: 29455927
Nat Rev Clin Oncol. 2017 Dec;14(12):717-734
pubmed: 28741618
J Cell Biol. 2018 Feb 5;217(2):459-472
pubmed: 29196460
Cell. 2019 Feb 7;176(4):897-912.e20
pubmed: 30686579
Nat Rev Drug Discov. 2018 Nov 28;17(12):854-855
pubmed: 30482962
Bioinformatics. 2016 Sep 15;32(18):2847-9
pubmed: 27207943
Sci Rep. 2017 Jan 13;7:40508
pubmed: 28084418
Cancer Immunol Immunother. 2018 Jun;67(6):981-988
pubmed: 28884365
Nature. 2020 Jan;577(7790):399-404
pubmed: 31915375
Oncogene. 2012 Oct 18;31(42):4499-508
pubmed: 22179834
Nature. 2017 Jan 18;541(7637):321-330
pubmed: 28102259
Nat Commun. 2018 Nov 9;9(1):4735
pubmed: 30413720
Nat Immunol. 2013 Jun;14(6):633-43
pubmed: 23624555
Cancer Immunol Res. 2014 Jul;2(7):655-67
pubmed: 24801837
Nature. 2018 Oct;562(7727):367-372
pubmed: 30283141
Cancer Biol Ther. 2006 Dec;5(12):1640-6
pubmed: 17106243
Front Oncol. 2018 Sep 25;8:390
pubmed: 30319963
Cancer Res. 1996 Jan 1;56(1):21-6
pubmed: 8548765

Auteurs

Florent Petitprez (F)

Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Team Inflammation, Complement and Cancer, F-75006, Paris, France. florent.petitprez@ligue-cancer.net.
Programme Cartes d'Identité des Tumeurs, Ligue Nationale contre le Cancer, F-75013, Paris, France. florent.petitprez@ligue-cancer.net.
Present address: MRC Centre for Reproductive Health, The University of Edinburgh, The Queen's Medical Research Institute, Edinburgh, UK. florent.petitprez@ligue-cancer.net.

Sacha Levy (S)

Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Team Inflammation, Complement and Cancer, F-75006, Paris, France.

Cheng-Ming Sun (CM)

Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Team Inflammation, Complement and Cancer, F-75006, Paris, France.

Maxime Meylan (M)

Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Team Inflammation, Complement and Cancer, F-75006, Paris, France.
Programme Cartes d'Identité des Tumeurs, Ligue Nationale contre le Cancer, F-75013, Paris, France.

Christophe Linhard (C)

Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Team Inflammation, Complement and Cancer, F-75006, Paris, France.

Etienne Becht (E)

Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Nabila Elarouci (N)

Programme Cartes d'Identité des Tumeurs, Ligue Nationale contre le Cancer, F-75013, Paris, France.

David Tavel (D)

Programme Cartes d'Identité des Tumeurs, Ligue Nationale contre le Cancer, F-75013, Paris, France.

Lubka T Roumenina (LT)

Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Team Inflammation, Complement and Cancer, F-75006, Paris, France.

Mira Ayadi (M)

Programme Cartes d'Identité des Tumeurs, Ligue Nationale contre le Cancer, F-75013, Paris, France.

Catherine Sautès-Fridman (C)

Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Team Inflammation, Complement and Cancer, F-75006, Paris, France.

Wolf H Fridman (WH)

Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Team Inflammation, Complement and Cancer, F-75006, Paris, France.

Aurélien de Reyniès (A)

Programme Cartes d'Identité des Tumeurs, Ligue Nationale contre le Cancer, F-75013, Paris, France. reyniesa@ligue-cancer.net.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH